• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Recap from Fall Clinical

Article

Catch up on coverage from the 2022 Fall Clinical Dermatology Conference.

The 2022 Fall Clinical Dermatology Conference took place in Las Vegas, Nevada this year from October 20-23. Editors of Dermatology Times® attended engaging sessions, networked with experts in the industry, and conducted interviews with key opinion leaders. Content from the meeting can be found below or on our Fall Clinical conference page.

What to Expect at the 2022 Fall Clinical Dermatology Conference

The 2022 Fall Clinical Dermatology Conference begins today in Las Vegas, Nevada, and continues through October 23rd.

Christopher Bunick, MD, Talks Antibiotic Stewardship at Fall Clinical

Christopher Bunick, MD, shares highlights of his session from the 2022 Fall Clinical conference in Las Vegas, Nevada, October 20-23.

Lisa Swanson, MD, FAAD, Talks About Fall Clinical

Lisa Swanson, MD, FAAD, a pediatric dermatologist in Boise, Idaho, presents all that is new and hot in pediatric dermatology at the 2022 Fall Clinical Conference in Las Vegas Nevada, October 20-23.

Raj Chovatiya, MD, PhD, Gets Excited About Presenting at Fall Clinical 2022

Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.

Matt Leavitt Shares His Pearls for Hair Loss Treatments at Fall Clinical

Matt Leavitt, DO, FAOCD, discusses highlights of his session on "Evaluating the Patient With Hair Loss" at this year's Fall Clinical conference in Las Vegas Nevada, October 20-23.

Applying New Technologies for Skin Cancers

At the 2022 Fall Clinical Dermatology Conference in Las Vegas, a look at the latest technology for treating basal cell carcinoma and nonmelanoma skin cancer.

Heather Ivy, DO, Explains Why She is Excited for Fall Clinical

As the 2022 Fall Clinical Dermatology Conference begins this week, Heathy Ivy, DO, regional medical director for LaserAway in Atlanta, Georgia, shares why she is looking forward to attending Fall Clinical.

The Best Cleansers for Your Patients

At the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss the best skin cleanser recommendations for their patients.

Zoe Diana Draelos, MD, Talks Cosmeceuticals at Fall Clinical

At the 2022 Fall Clinical Conference in Las Vegas, Nevada, Dermatology Times editor-in-chief, Zoe Diana Draelos, discusses her session on the latest trends in cosmeceuticals.

JAK Inhibitors for the Management of Atopic Dermatitis

Lisa Swanson, MD, FAAD, and James Q. Del Rosso, DO, FAOCD, FAAD, gave an in-depth discussion on Janus kinase (JAK) inhibitors for the management of atopic dermatitis at the 2022 Fall Clinical Dermatology Conference.

What’s New and Hot in Acne and Rosacea

At the 2022 Fall Clinical Dermatology Conference, Valerie D. Callender, MD, FAAD, presents “What’s Hot in Acne & Rosacea.”

What's New and Hot in Infectious Disease

At the 2022 Fall Clinical Dermatology Conference, a look at the latest treatments for monkeypox, HIV, and more.

How Spesolimab Will Revolutionize Generalized Pustular Psoriasis Flares Treatment

Aaron Farberg, MD, presents study data and efficacy of spesolimab for the treatment of generalized pustular psoriasis at the 2022 Fall Clinical Dermatology Conference.

Using Diagnostic Tools for Melanoma

At a session at the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss some of the top testing methods for skin cancer.

Consistent Efficacy With a Durable Safety Profile Through 5 Years and a Growing Body of Real-World Evidence

At the 2022 Fall Clinical Dermatology Conference in Las Vegas, Aaron S. Farberg, MD, shares data on the treatment of plaque psoriasis using tildrakizumab-asmn.

Neal D. Bhatia, MD, Talks Photodynamic Therapy at Fall Clinical

Neal D. Bhatia, MD, discusses the nuances of photodynamic therapy in a session at Fall Clinical in Las Vegas, Nevada, October 20-23.

Exploring What’s Possible for HS Treatment

At the 2022 Fall Clinical Dermatology Conference, Joslyn R. Sciacca Kirby, MD, MS, MEd, and Raj Chovatiya, MD, PhD, discussed how there is a large unmet need for hidradenitis suppurativa treatment and what future treatment could look like.

How Mohs Surgeons Use Prognostic Testing for High-Risk SCC

The 40-gene expression profile (40-GEP) test can focus treatment options and optimize patient outcomes, according to a poster presentation at the 2022 Fall Clinical Dermatology Conference.

What's New and Hot in Nail and Hair Treatments

At the 2022 Fall Clinical Dermatology Conference, a presenter looks at the best treatments for hair loss and nail fungus.

How to Diagnose and Manage Alopecia Areata

At the 2022 Fall Clinical Dermatology Conference, 3 expert clinicians share their strategies for diagnosing and managing alopecia areata.

Learn From the Derm Experts

At the 2022 Fall Clinical Dermatology Conference, 5 practitioners share their best tips for treating their patients.

A Young Physician's Guide to Diagnosing Atopic Dermatitis

At the 2022 Fall Clinical Dermatology Conference, one clinician discusses history, definitions, and diagnosis for this common skin affliction.

Defining a New Era for Patients with PsO and PsA

At the 2022 Fall Clinical Dermatology Conference, Bruce E. Strober, MD, PhD, reviewed the best treatment options for patients with psoriasis and psoriatic arthritis.

Treating Skin Cancers in the Immunotherapy Era

At the 2022 Fall Clinical Dermatology Conference, a dermatologist shares results of using cemiplimab-rwlc (Libtayo) for basal and squamous cell carcinoma.

























Related Videos
© 2024 MJH Life Sciences

All rights reserved.